Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 85%
filed 2026-07-16
The filing discloses two board appointments on July 15, 2026: Guibao Ji (the Company's CFO) and Alejandro Quiles, with Quiles designated as Compensation Committee chairman and determined to be independent under Nasdaq Rule 5605(a)(2). While the filing also mentions Chenlong Liu's resignation on July 10, the principal disclosed action centers on the two new director appointments and their committee assignments, making exec_appointment the most salient classification. The appointments are material to investors as they affect board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
The filing discloses that on July 15, 2026, the board of directors appointed Michael Regan as Chief Operating Officer and Secretary of SHF Holdings, Inc. This is a clear executive appointment to a material officer position. The disclosure is made under Item 5.02, which covers both departures and appointments, and the principal action disclosed is the appointment of an officer to a senior operational role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses that Hayden Brown, the Company's President and CEO, has been appointed to assume the role of interim principal financial officer effective July 14, 2026, during CFO Erica Gessert's temporary medical leave. While the departure of the CFO is also mentioned, the principal disclosed action is the appointment of Brown to the interim CFO role. This is material because it involves a change in the principal financial officer position, a key executive role affecting investor confidence in financial reporting and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of Bobby L. Owens as General Counsel effective July 13, 2026, with detailed compensation terms including $325,000 base salary, 60% bonus target, $100,000 sign-on equity award, and severance provisions. While the section also mentions Jonathan Norling's termination as Chief Legal Officer, the principal disclosed action centers on the appointment of a new named executive officer with a comprehensive offer letter. The appointment of a General Counsel to lead the company's legal function is material to investors assessing management quality and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Christopher Peetz was appointed as a new member of the Board of Directors effective July 15, 2026, with the Board increasing authorized directors from nine to ten. Peetz brings extensive biopharmaceutical leadership experience, including his current CEO role at Mirum Pharmaceuticals, and received an initial stock option award of 21,486 shares plus prorated annual equity and cash retainer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
BuzzFeed appointed Stanley E. Washington as an independent director effective July 16, 2026, with assignment as Chair of the Compensation Committee. The appointment reflects a significant board composition change tied to the Allen Family Digital investment transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of two Class III directors, Justyn Feldman and Sanghyun Lee, to Douglas Elliman's Board effective July 10, 2026. The principal disclosed action is the taking of board roles by these individuals, making this an executive appointment event. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
American Airlines elected John W. Dietrich to its Board of Directors, assigning him to the Audit Committee and Finance Committee. Dietrich brings 35 years of aviation and financial leadership experience, including service as CFO of FedEx and President/CEO of Atlas Air, strengthening the company's governance and financial oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Robert Osborn was appointed as Controller and principal accounting officer of AES Ohio on July 10, 2026, by unanimous Board consent. This is a material executive appointment to a principal accounting officer role, a position responsible for financial reporting and internal controls. The disclosure includes his background, qualifications, and compensation arrangements, consistent with Item 5.02(c) appointment disclosures.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Robert Osborn was appointed as Controller and principal accounting officer of IPALCO and AES Indiana on July 10, 2026, by unanimous written consent of the Boards of Directors. This is a clear executive appointment to a principal accounting officer role, which is a material officer position. While Sherry Kohan's role was modified (retaining CFO but relinquishing Controller duties), the principal disclosed action is Osborn's appointment to the Controller position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The Hartford Insurance Group, Inc. elected Randy Larsen as a director, effective September 1, 2026, with appointment to two board committees. Larsen is an experienced insurance-industry executive with 13 years at AssuredPartners (including CEO service) and 14 years at Schifman Remley & Associates. The appointment includes compensatory arrangements of $82,700 in cash retainer and $136,600 in RSU equity compensation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of Brent MacDonald to Socket Mobile's Board of Directors effective July 13, 2026. MacDonald, who previously served on the Board from 2016 to 2023, has been reappointed as an independent director. This is a clear executive appointment event under Item 5.02, and the Board's determination of his independence status and standard director compensation arrangements are disclosed. The appointment is material as it affects the composition and governance of the company's board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of James H. Bradshaw as a member of RLI's Board of Directors, effective July 15, 2026, with assignment to the Audit and Finance & Risk Committees. The principal disclosed action is a person taking a role (board appointment), making this an exec_appointment event. The appointment of a director with significant industry experience (40+ years in insurance leadership) to key board committees is material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-07-15
EX-99.1
The exhibit discloses the appointment of Dr. Jeff Millard as Executive Vice President, Technical Operations effective July 13, 2026, and the elevation of Dr. Alex Therien to Executive Vice President, Research & Development. While the filing also mentions Amanda Malone's departure as Chief Scientific and Operating Officer, the primary announced action is the appointment of new executive leadership to support the company's clinical and commercial development. The material change report emphasizes these leadership updates as part of the company's evolution and operational restructuring.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of Reza Zadno, Ph.D. as a new director to Mobia Medical's Board, increasing the Board size from six to seven members. Dr. Zadno was also appointed to the Compensation Committee as an independent director. This is a clear executive appointment event under Item 5.02(d), and is material as board composition changes affect corporate governance and investor assessment of the company's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Aziz Mottiwala was appointed as President and Chief Executive Officer effective July 20, 2026, replacing Ron Kurtz, M.D., who transitioned to Chief Medical Officer. Mottiwala was also appointed to the Board of Directors with detailed employment terms including $14 million in equity awards.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-15
EX-99.1
The press release announces the appointment of John M. Melkon to the board of directors of Skyline Builders Group Holding Limited, effective immediately. The disclosure also notes that Ngo Chiu Lam is stepping down from the board concurrently. The appointment of a director with significant expertise in critical materials supply chains and geopolitical operations is material to investors evaluating the company's strategic pivot from Asian construction to critical minerals supply, particularly given the pending merger with Cove Kaz and the company's stated objective to become a strategic supplier to the U.S. defense and industrial base.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-15
The 6-K discloses the appointment of Mr. Ning Xue as an independent director effective July 14, 2026, along with his appointment as Chairperson of the Nominating and Corporate Governance Committee and member of the Audit and Compensation Committees. While Dr. Jiayuan Tong's resignation is also mentioned, the principal disclosed action is the appointment of a new director to fill the vacancy, making this an exec_appointment event. The appointment includes detailed background on Mr. Xue's qualifications and compensation terms ($14,082 for the initial term).
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-15
EX-99.1
The press release announces the appointment of Rodrigo Natale as Chief Financial Officer of Nuvini Group Limited, effective July 20, 2026. This is a clear executive appointment of a named officer to a senior leadership role. The appointment is material because it fills a CFO vacancy that had existed since February 2026 (when Roberto Otero resigned) and restores dedicated financial oversight and governance to the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 7.01
The filing announces the appointment of Michael Deal as Senior Vice President and Chief Operating Officer of Hycroft Mining, effective August 24, 2026. The press release (Exhibit 99.1) emphasizes his 20+ years of operating and technical leadership experience in gold and silver mining operations, his prior role at First Majestic Silver managing a $1 billion acquisition integration, and his direct relevance to Hycroft's strategy of advancing the Hycroft Mine. This is a material executive appointment to a senior operational leadership position.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-15
The 6-K discloses the appointment of three executives effective July 13, 2026: Ms. Chen Shulan as Executive Chairman and Director (with US$300,000 annual base compensation), Ms. Lim Hui Leng as independent Director and Audit Committee Chairman (US$20,000 annual fee), and Mr. Yuen Jia Feng Leonard as Chief Financial Officer (SGD 10,500 monthly salary). These are material leadership changes affecting the registrant's governance and financial oversight structure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-15
The exhibit discloses the appointment of Mr Mark Hoffman as an independent non-executive director of DRDGOLD effective August 1, 2026. This is a clear executive/board appointment requiring disclosure under JSE Listings Requirements paragraph 6.71(a). The appointment of a director with significant professional credentials (Chartered Accountant, 35+ years in professional services, former Deloitte and KPMG partner) is material to investors' assessment of board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-15
Item 5.02
The filing discloses the appointment of John Markels to the Board as a Class II director effective July 16, 2026, with concurrent appointment to the Audit Committee and Compensation Committee. While the section also mentions Heath Lukatch's retirement, the principal disclosed action centers on the new director appointment and his committee assignments. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-15
Item 5.02
Timothy Dugan was appointed to the Board of Directors of Infinity Natural Resources, Inc. effective July 13, 2026, to fill a current vacancy. The Board affirmatively determined his independence, and Dugan brings extensive executive leadership experience spanning four decades in the Appalachian energy industry, including prior roles as CEO and COO at major energy companies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Britt Vitalone was appointed to Cheniere's Board of Directors effective July 14, 2026, with assignment to the Audit and Compensation Committees. Vitalone brings 30+ years of executive leadership experience, including his recent role as Executive Vice President and Chief Financial Officer at McKesson Corporation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Christian M. Lown was appointed as Executive Vice President and Chief Financial Officer of The Allstate Corporation, effective August 3, 2026. The appointment includes a base salary of $875,000, a sign-on bonus of $2,000,000, and equity grants. Lown brings 25+ years of senior leadership experience in finance and capital markets, including prior CFO roles at CoStar Group, Freddie Mac, and Navient Corporation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
Kelly E. Garcia was appointed as Chief Technology Officer of Ulta Beauty, effective August 31, 2026, bringing more than 25 years of leadership experience in e-commerce, customer loyalty, digital innovation, and cybersecurity to support the company's technology strategy.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-14
The 6-K discloses the appointment of two new directors effective July 10, 2026: Ms. Mei Ting Yeung (appointed as director, Chair of the Audit Committee, and committee member) and Mr. Wei Li (appointed as director and committee member). While the filing also mentions two concurrent resignations, the principal disclosed action is the appointment of these new board members with detailed biographical information and committee assignments. The appointments are material to investors as they affect board composition and audit committee leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Zachary F. Sadek was appointed to the Board of Directors effective July 13, 2026, pursuant to a Cooperation Agreement with PCP Managers II, L.P. (Parthenon Capital), one of the Company's largest stockholders, expanding the board from six to seven members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
Alan Musso and John Maslowski were appointed to the Board of Directors effective July 10, 2026, in connection with the Company's IPO, with concurrent appointments to the Audit, Nominating, and Compensation committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
The Board appointed two new directors, Christopher Riccardi and Greg Voorhies, effective July 11, 2026, with terms expiring at the 2028 annual meeting. This is a clear director appointment disclosure under Item 5.02, and director appointments are material events affecting the composition and governance of the company's board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
The filing discloses the appointment of Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. While the disclosure also includes compensatory arrangements (base salary of $440,000, annual bonus eligibility, and stock option grant of 750,000 shares), the principal action is the appointment of a named executive officer to a C-suite position. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
PVH Corp. announced the appointment of Alexis Rollier as Chief Financial Officer, effective early September 2026, replacing interim CFO Melissa Stone. The filing discloses a detailed employment agreement with compensation terms including $850,000 base salary, bonus opportunities up to 200% of base, and equity awards totaling approximately $2.825 million in PSUs, RSUs, and sign-on awards. This is a material executive appointment to a principal officer position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
The filing discloses the appointment of Paul Lapping as a director of Churchill Capital Corp XII effective July 13, 2026, along with his appointment to the compensation and audit committees and as audit committee chairperson. While the section also mentions director compensation agreements, the principal disclosed action is the appointment of a new director to the board and committee positions, making exec_appointment the most salient event type.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
Domino's appointed Michael C. Creedon, Jr. (former CEO of Dollar Tree) and Anneliese Olson (former President of HP's Imaging, Printing and Solutions division) to the Board of Directors effective July 15, 2026, increasing the Board size from eight to ten directors.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-14
Vale's Board of Directors elected Mr. Wilfred Theodoor Bruijn, an independent board member, to serve as Chairman of the Board of Directors, filling a vacancy that arose on July 6, 2026. The appointment of a Chairman is a material governance event affecting the registrant's leadership structure and would influence a reasonable investor's assessment of the company's governance and direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-14
Item 5.02
The filing discloses the appointment of Michael Jennings and Zamir Rauf to the Board of Directors of the General Partner, effective July 14, 2026, with detailed descriptions of their qualifications and committee assignments. While the disclosure also includes compensatory arrangements (phantom units and cash fees) and the resignations of two directors, the principal action is the appointment of two new independent directors with substantial energy-sector experience. This is material to investors as board composition affects governance and oversight.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-14
EX-99.1
The exhibit is a press release announcing the appointment of Gadi Levin as Chief Financial Officer of A2Z Cust2Mate Solutions Corp. effective immediately. The disclosure explicitly states "Gadi Levin has been appointed Chief Financial Officer" and includes quotes from the Executive Chair endorsing his qualifications and experience. This is a clear executive appointment of a named executive officer to a material position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-14
Item 5.02
The filing discloses both a director departure (Annie Van Broekhoven's retirement and resignation from the Board effective July 8, 2026) and a director appointment (Carlo Campiciano appointed to the Board the same day). While both events occurred, the principal disclosed action centers on the appointment of Campiciano, with detailed biographical information provided about his qualifications, experience as CFO and Company Secretary of MedAdvisor Limited, and expertise in finance, taxation, and corporate governance. The appointment is the forward-looking action that fills the vacancy and is material to investors assessing board composition.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-07-14
The 6-K discloses two material executive changes effective July 1, 2026: Mr. Hiroshi Furukawa's promotion from CEO to Chairman and CTO, and Mr. Hideaki Horikiri's promotion from CFO to President and COO. While the filing also mentions Mr. Toshihito Kanai's resignation as CTO and Director, the principal disclosed actions are the appointments/promotions of Furukawa and Horikiri to new executive roles. Both remain principal executive and financial officers respectively under SOX, making these material governance events affecting leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-14
Item 5.02
Alex Shootman was appointed to PagerDuty's Board of Directors effective July 14, 2026, and simultaneously appointed to the Audit Committee and Compensation Committee. Shootman brings 25+ years of operating experience and prior CEO roles at Workfront and Eloqua, representing a material change to the company's board composition and governance oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 88%
filed 2026-07-14
Item 5.02
Stan Guidroz was appointed Chief Operating Officer of Accel Entertainment effective July 14, 2026, representing a material appointment to a C-suite operational leadership role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
Kyle Callaway was appointed Chief Accounting Officer effective July 10, 2026, a named executive officer role. The disclosure centers on the appointment action itself—a promotion from Controller to CAO—with detailed background on his qualifications and prior experience. This is a material executive appointment that would affect investor assessment of the company's financial leadership and accounting oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-14
Item 5.02
The disclosure centers on the Board's appointment of Gregory L. Heston as a Class III director effective July 10, 2026, filling a vacancy created by David Kornblatt's resignation. While the resignation is mentioned, the principal action disclosed is Heston's appointment to the Board and assignment to the Audit Committee. His extensive background as a retired EY audit partner with 38 years of public accounting experience and CPA credentials makes this a material governance event affecting the registrant's board composition and audit oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
Robert Brackenbury was appointed to the Board of Directors as a Class I director on July 9, 2026, and will serve on the audit committee. The disclosure centers on the appointment of a new director with substantial experience in investment management and governance, making this a material executive appointment under Item 5.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 93%
filed 2026-07-13
Item 5.02
Robin Rossmann was appointed Chief Financial Officer of CoStar Group effective July 31, 2026, succeeding Christian Lown. The appointment includes significant compensatory arrangements ($590,000 base salary, $2.5M equity grant, $500K relocation subsidy) and is material as it involves a key C-suite executive position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The filing discloses the appointment of Anthony Pierce as a Class III director effective immediately, approved by the Board on July 9, 2026. While the disclosure also includes compensatory details (annual cash retainer of $55,000 and equity grant of $300,000), the principal action is the appointment itself. The Board expanded the authorized number of directors from 10 to 11 specifically to accommodate this appointment, making the directorship the salient event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-13
Item 5.02
The filing discloses both the resignation of Edward M. Weil, Jr. as Chairman and director (effective July 9, 2026) and the appointment of Nicholas S. Schorsch, Jr. as Class III director and Chairman on July 10, 2026. While both events occurred, the principal action disclosed is the appointment of a new Chairman to fill the vacancy, making exec_appointment the most salient classification. Schorsch, Jr. was already serving as CEO since March 2025 and brings substantial real-estate and capital markets experience, making this a material leadership transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-13
Item 5.02
The filing discloses the appointment of Barend (Barrie) J. van der Merwe, the current Chief Financial Officer, to the position of Chief Executive Officer effective August 1, 2026, along with his election as Managing Director of the Board. While the section also covers the departure of the interim CEO (Spindler) and appointment of an interim CFO (Deoji), the principal disclosed action centers on the appointment of a new CEO—a material executive leadership change. The detailed compensation terms and board expansion to accommodate this appointment further underscore the materiality of this executive appointment event.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-07-13
EX-99.1
The press release announces the appointment of Dr. Jeff Millard as Executive Vice President, Technical Operations, effective July 13, 2026, and the promotion of Dr. Alex Therien to Executive Vice President, Research & Development. While the release also discloses Amanda Malone's departure as Chief Scientific and Operating Officer, the principal disclosed action is the addition of experienced executive leadership to support the company's transition to late-stage development ahead of the Q4 2026 RESOLVE trial interim release. This is material to investors assessing management capability during a critical growth phase.
View raw filing on EDGAR →